Un nouveau type de traitement médical pourrait mener à la régression de la sténose valvulaire aortique

David Busseuil; Eric Rhéaume; Jean-Claude Tardif

doi:10.1051/medsci/20082489675

Accueil

Tous les numéros

Volume 24 / Numéro 8-9 (Août-Septembre 2008)

Med Sci (Paris), 24 8-9 (2008) 675-676

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 24, Numéro 8-9, Août-Septembre 2008


Page(s)		675 - 676
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20082489675
Publié en ligne		15 août 2008

Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111 : 3316–26. [Google Scholar]
Carabello BA. Aortic stenosis. N Engl J Med 2002; 346 : 677–82. [Google Scholar]
Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290 : 2292–300. [Google Scholar]
Tardif JC, Grégoire J, L’Allier PL, et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 2007; 297 : 1675–82. [Google Scholar]
Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-I (milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 2001; 103 : 3047–50. [Google Scholar]
Meyers CD, Kashyap ML. Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies. Curr Opin Cardiol 2005; 20 : 307–12. [Google Scholar]
Busseuil D, Shi Y, Mecteau M, et al. Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits. Br J Pharmacol 2008; 154 : 765–73. [Google Scholar]
Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003; 41 : 1211–7. [Google Scholar]
Khan M, Lalwani ND, Drake SL, et al. Single-dose intravenous infusion of ETC-642, a 22-Mer ApoA-I analogue and phospholipids complex, elevates HDL-C in atherosclerosis patients. Circulation 2003; 108 (suppl IV) : 563–4. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111 : 3316–26. [Google Scholar]

[2] Carabello BA. Aortic stenosis. N Engl J Med 2002; 346 : 677–82. [Google Scholar]

[3] Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290 : 2292–300. [Google Scholar]

[4] Tardif JC, Grégoire J, L’Allier PL, et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 2007; 297 : 1675–82. [Google Scholar]

[5] Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-I (milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 2001; 103 : 3047–50. [Google Scholar]

[6] Meyers CD, Kashyap ML. Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies. Curr Opin Cardiol 2005; 20 : 307–12. [Google Scholar]

[7] Busseuil D, Shi Y, Mecteau M, et al. Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits. Br J Pharmacol 2008; 154 : 765–73. [Google Scholar]

[8] Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003; 41 : 1211–7. [Google Scholar]

[9] Khan M, Lalwani ND, Drake SL, et al. Single-dose intravenous infusion of ETC-642, a 22-Mer ApoA-I analogue and phospholipids complex, elevates HDL-C in atherosclerosis patients. Circulation 2003; 108 (suppl IV) : 563–4. [Google Scholar]